Abstract
In the course of screening for a new type of androgen receptor (AR) antagonist, we isolated a novel compound, arabilin, with two structural isomers, spectinabilin and SNF4435C, produced by Streptomyces sp. MK756-CF1. Structure elucidation on the basis of the spectroscopic properties showed that arabilin is a novel polypropionate-derived metabolite with a p-nitrophenyl group and a substituted γ-pyrone ring. Arabilin competitively blocked the binding of androgen to the ligand-binding domain of AR in vitro. In addition, arabilin inhibited androgen-induced prostate-specific antigen mRNA expression in prostate cancer LNCaP cells.
Original language | English |
---|---|
Pages (from-to) | 601-605 |
Number of pages | 5 |
Journal | Journal of Antibiotics |
Volume | 63 |
Issue number | 10 |
DOIs | |
Publication status | Published - 2010 Oct |
Externally published | Yes |
Keywords
- Androgen antagonist
- PSA
- prostate cancer
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery